BioCryst Pharmaceuticals Inc
BCRX
$8.78+0.23%
End of day · as of Sep 22, 2026, 10:46 PM ET
Mkt cap
$1.83B
EV/Sales
1.99
P/E ratio
N/A
FY2025 Revenue
$874.84M
EPS (TTM)
$-1.40
Gross Margin (FY2025)
97.82%
Profit Margin (FY2025)
30.16%
Beta
1.10
Div yield
N/A
Sector
Healthcare
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BCRX revenue for 2025-12-31 was $874.8M. Net income was $263.9M. Revenue was up 94.1% from 2024-12-31 to 2025-12-31. BCRX currently screens at market cap $1.83B.
Use this BCRX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BCRX income, balance, and cash tables.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached BioCryst Pharmaceuticals Inc (BCRX) revenue for Dec 31, 2025 was $874.8M. Net income was $263.9M. Statements: https://lician.com/financials/bcrx
BioCryst Pharmaceuticals Inc (BCRX) market capitalization is $1.83B on the latest cached snapshot.
BioCryst Pharmaceuticals Inc (BCRX) cached previous close $8.76; day range $8.72 – $9.04; volume 3,271,633. Session quote: https://lician.com/quote/bcrx
BioCryst Pharmaceuticals Inc (BCRX) latest cached earnings event is "BCRX earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BCRX filing is 8-K · Aug 5, 2026. Filings: https://lician.com/sec/bcrx